Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ProPhase Labs, Inc. - Common Stock (NQ: PRPH )

0.3250 -0.0150 (-4.41%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ProPhase Labs, Inc. - Common Stock

< Previous 1 2 3 4 Next >
DSS Inc. Is Spinning Off Its Biotech Subsidiary After Signing A Major Licensing Agreement
By David Willey, Benzinga 
Via TheNewswire.com
DSS Inc. Is Spinning Off Its Biotech Subsidiary After Signing A Major Licensing Agreement
DSS, Inc. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Analyst Expectations for ProPhase Labs's Future
Via Benzinga
Recap: ProPhase Labs Q1 Earnings
Via Benzinga
7 Small-Cap Biotech Stocks with Massive Potential
Although small-cap biotech stocks present high risks, if they hit one out of the park, the rewards can be astronomical. 
Via InvestorPlace
Overview Of Value Stocks In The Healthcare Sector
Via Benzinga
ProPhase Labs Earnings Preview
Via Benzinga
A Look Into Healthcare Sector Value Stocks
Via Benzinga
5 Value Stocks In The Healthcare Sector
Via Benzinga
Impact Biomedical Preparing A Potential Spinoff — What Does This Mean For Investors Of Holding Company DSS, Inc (NYSE American: DSS)?
Impact Biomedical, a biotechnology company focused on developing innovative treatments for a wide range of diseases and conditions and one of the key businesses in the DSS Inc. (NYSE American: DSS)... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
ProPhase Labs's Return On Capital Employed Overview
Via Benzinga
5 Value Stocks In The Healthcare Sector
Via Benzinga
ProPhase Labs to Present at the Planet MicroCap Showcase: VIRTUAL 2022 on Wednesday, December 7, 2022
From ProPhase Labs, Inc.
Via GlobeNewswire
Earnings Scheduled For August 11, 2022
Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million. 
Via Benzinga
ProPhase Labs Announces Record Third Quarter 2022 Financial Results
From ProPhase Labs, Inc.
Via GlobeNewswire
ProPhase Labs Announces Collaboration with Dana-Farber Cancer Institute
From ProPhase Labs, Inc.
Via GlobeNewswire
ProPhase Labs to Present at Investor Summit Group’s Q4 Conference
From ProPhase Labs, Inc.
Via GlobeNewswire
ProPhase Labs to Host Third Quarter 2022 Financial Results Conference Call on Thursday, November 10, 2022 at 11:00 a.m. Eastern Time
From ProPhase Labs, Inc.
Via GlobeNewswire
Why Olaplex Shares Dipped Around 57%; Here Are 75 Biggest Movers From Yesterday
Gainers Amprius Technologies, Inc. (NYSE: AMPX) jumped 77.3% to settle at $11.01 on Wednesday after the company announced it was awarded a $50 million cost-sharing grant from the U.S. Department of... 
Via Benzinga
Why United Airlines Shares Are Trading Higher? Here Are 43 Stocks Moving In Wednesday's Mid-Day Session
Gainers SenesTech, Inc. (NASDAQ: SNES) shares jumped 102.6% to $0.47 after declining over 3% on Tuesday. SenesTech, during August, posted a Q2 loss of $0.21 per share. 
Via Benzinga
ProPhase Labs Announces Collaboration with G42 Healthcare
From ProPhase Labs, Inc.
Via GlobeNewswire
ProPhase Labs to Present at The ThinkEquity Conference
From ProPhase Labs, Inc.
Via GlobeNewswire
Nebula Genomics Strengthens Advisory Board with Appointment of Russ Altman, M.D., Ph.D.
From ProPhase Labs, Inc.
Via GlobeNewswire
A Look Into Healthcare Sector Value Stocks
What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base... 
Via Benzinga
Colgate Stock Lingers Near Earlier All-Time High; Ready To Rise?
Colgate stock is working on a consolidation with an 85.71 entry. See if it can clear the breakout price in strong volume. 
Via Investor's Business Daily
ProPhase Labs Announces New $6 Million Stock Repurchase Plan
From ProPhase Labs, Inc.
Via GlobeNewswire
This Technology Stock Surged 235%; Here Are 77 Biggest Movers From Friday
Gainers 
Via Benzinga
This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday
 Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up period... 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.